Scalable Immunoassays The company’s automated nanoliter immunoassay platforms (Gyrolab xPand and xPlore) enable high-throughput workflows; position as opportunity to upsell instrument upgrades, service contracts, and validation support to biopharma customers scaling preclinical to manufacturing.

HCP Kit Expansion Recent launches of HEK293 host cell protein kits create cross-sell opportunities for additional reagents, standards, and method validation services to biotechs and pharma firms aiming for regulatory-compliant impurity profiling.

Residual dsRNA Automated dsRNA residual assays offer a differentiated service line; target development labs seeking robust analytics that meet LOD and LLOQ performance, offering method transfer, training, and consulting bundled with instruments and consumables.

CRO Collaboration Gyrolab CRO Certification Program positions GPT as a preferred automation partner for CROs; sales pitch to CRO networks and service providers to broaden adoption of automated immunoassays and reagent kits across projects.

Integrated Workflows The dual strength in peptide synthesis (PurePep, Symphony, Sonata+) and immunoassay platforms allows cross-sell of synthesis reagents and integrated workflows to drug discovery and bioprocess teams seeking end-to-end solutions.